Melatonin and human cardiovascular disease

Pandi Perumal, Seithikurippu R.; BaHammam, Ahmed S.; Ojike, Nwakile I.; Akinseye, Oluwaseun; Kendzerska, Tetyana; Buttoo, Kenneth; Dhandapany, Perundurai S.; Brown, Gregory M.; Cardinali, Daniel Pedro

Please use this identifier to cite or link to this item: https://repositorio.uca.edu.ar/handle/123456789/1467

Título :	Melatonin and human cardiovascular disease
Autor :	Pandi Perumal, Seithikurippu R. BaHammam, Ahmed S. Ojike, Nwakile I. Akinseye, Oluwaseun Kendzerska, Tetyana Buttoo, Kenneth Dhandapany, Perundurai S. Brown, Gregory M. Cardinali, Daniel Pedro
Palabras clave :	MEDICINA; MELATONINA; PRESION SANGUINEA; ENFERMEDADES CARDIOVASCULARES; HIPERTENSION
Fecha de publicación :	2017
Editorial :	SAGE Publications
Cita :	Pandi-Perumal, S. R., et al. Melatonin and human cardiovascular disease [en línea]. Preprint del documento publicado en Journal of Cardiovascular Pharmacology and Therapeutics. 2017, 22 (2). doi: 10.1177/1074248416660622. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1467
Resumen :	Abstract: The possible therapeutic role of melatonin in the pathophysiology of coronary artery disorder (CAD) is increasingly being recognized. In humans, exogenous melatonin has been shown to decrease nocturnal hypertension, improve systolic and diastolic blood pressure, reduce the pulsatility index in the internal carotid artery, decrease platelet aggregation and reduce serum catecholamine levels. Low circulating levels of melatonin are reported in individuals with CAD, arterial hypertension and congestive heart failure. This review assesses current literature on the cardiovascular effects of melatonin in humans. It can be concluded that melatonin deserves to be considered in clinical trials evaluating novel therapeutic interventions for cardiovascular disorders.
URI :	https://repositorio.uca.edu.ar/handle/123456789/1467
ISSN :	1940-4034 (en línea)
Disciplina:	MEDICINA
Derechos:	Acceso Abierto
Appears in Collections:	Artículos